Patents by Inventor David Jonathan Madge

David Jonathan Madge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100113393
    Abstract: Salts of a peptide boronic acid drug, for example of Cbz-(R)-Phe-(S)-Pro-(R)-Mpg-B(OH)2. The counter-ion to the boronate may be an alkali metal or derived from a strongly basic organic nitrogen-containing compound.
    Type: Application
    Filed: June 9, 2009
    Publication date: May 6, 2010
    Inventors: David Jonathan Madge, Mark Dolman, John Joseph Deadman, Anthony James Kennedy, Sophie Marie Combe-Marzelle, Sanjay Kumar Kakkar
  • Publication number: 20100035827
    Abstract: Salts of a pharmaceutically acceptable divalent metal and an organoboronic acid drug. Examples of such metals are calcium, magnesium and zinc. The organoboronic acid drug may be a boropeptide protease inhibitor. The salts may be formulated in oral dosage form.
    Type: Application
    Filed: February 26, 2009
    Publication date: February 11, 2010
    Inventors: John Joseph Deadman, David Jonathan Madge, Mark Dolman, Sanjay Kumar Kakkar, Anthony James Kennedy, Sophie Marie Combe-Marzelle, Suresh Babubhai Chahwala, Oliver Vimpany Arnold Boucher
  • Publication number: 20080287370
    Abstract: Salts of a peptide boronic acid drug, for example of Cbz-(R)-Phe-(S)—Pro-(R)-Mpg-B(OH)2. The counter-ion to the boronate may be an alkali metal or derived from a strongly basic organic nitrogen-containing compound.
    Type: Application
    Filed: April 24, 2008
    Publication date: November 20, 2008
    Inventors: David Jonathan MADGE, Mark Dolman, Sophie Marie Combe-Marzelle, John Joseph Deadman, Anthony James Kennedy, Sanjay Kumar Kakkar
  • Publication number: 20080234228
    Abstract: Salts of a peptide boronic add drug, for example of Cbz-(R)-Phe-(S)-Pro-(R)-Mpg-B(OH)2. The counter-ion to the boronate may be an alkali metal or derived from a strongly basic organic nitrogen-containing compound.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 25, 2008
    Inventors: David Jonathan Madge, Mark Dolman, John Joseph Deadman, Anthony James Kennedy, Sophie Marie Combe-Marzelle, Sanjay Kumar Kakkar
  • Patent number: 7371729
    Abstract: Salts of a peptide boronic acid drug, for example of Cbz-(R)-Phe-(S)-Pro-(R)-Mpg-B(OH)2. The counter-ion to the boronate may be an alkali metal or derived from a strongly basic organic nitrogen-containing compound.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: May 13, 2008
    Assignee: Trigen Limited
    Inventors: David Jonathan Madge, Mark Dolman, Sophie Marie Combe-Marzelle, John Joseph Deadman, Anthony James Kennedy, Sanjay Kumar Kakkar
  • Patent number: 7112572
    Abstract: Salts of a pharmaceutically acceptable divalent metal and an organoboronic acid drug. Examples of such metals are calcium, magnesium and zinc. The organoboronic acid drug may be a boropeptide protease inhibitor. The salts may be formulated in oral dosage form.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: September 26, 2006
    Assignee: Trigen Limited
    Inventors: John Joseph Deadman, David Jonathan Madge, Mark Dolman, Sanjay Kumar Kakkar, Anthony James Kennedy, Sophie Marie Combe-Marzelle, Suresh Babubhai Chahwala, Oliver Vimpany Arnold Boucher
  • Publication number: 20040147453
    Abstract: Salts of a pharmaceutically acceptable divalent metal and an organoboronic acid drug. Examples of such metals are calcium, magnesium and zinc. The organoboronic acid drug may be a boropeptide protease inhibitor. The salts may be formulated in oral dosage form.
    Type: Application
    Filed: September 9, 2003
    Publication date: July 29, 2004
    Applicant: Trigen Limited
    Inventors: John Joseph Deadman, David Jonathan Madge, Mark Dolman, Sanjay Kumar Kakkar, Anthony James Kennedy, Sophie Marie Combe-Marzelle, Suresh Babubhai Chahwala, Oliver Vimpany Arnold Boucher
  • Publication number: 20040138175
    Abstract: Salts of a peptide boronic acid drug, for example of Cbz—(R)—Phe—(S)—Pro—(R)—Mpg—B(OH)2. The counter-ion to the boronate may be an alkali metal or derived from a strongly basic organic nitrogen-containing compound.
    Type: Application
    Filed: September 9, 2003
    Publication date: July 15, 2004
    Applicant: Trigen Limited
    Inventors: David Jonathan Madge, Mark Dolman, Sophie Marie Combe-Marzelle, John Joseph Deadman, Anthony James Kennedy, Sanjay Kumar Kakkar